...^ chlorpyrifos is one of the compounds." FAAH inhibitors Fabien Vincent, senior scientist at the Renovis Inc.... ...told SciBX . Evotec gained an FAAH inhibitor program when it completed its acquisition of Renovis...
...Evotec completed its previously announced acquisition of Renovis for about 35 million shares valued at E58.8... ...before the deal closed (see BioCentury, Sept. 24, 2007). Evotec AG (Xetra:EVT; NASDAQ:EVTC), Hamburg, Germany Renovis Inc....
...running into Phase III difficulties in late-stage testing include both a neuroprotectant, NXY-059 (Cerovive) from Renovis Inc.... ...NYSE:NVS; SWX:NOVN), Basel, Switzerland Paion AG (FSE:PA8), Aachen, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Renovis Inc....
...^ chlorpyrifos is one of the compounds." FAAH inhibitors Fabien Vincent, senior scientist at the Renovis Inc.... ...told SciBX . Evotec gained an FAAH inhibitor program when it completed its acquisition of Renovis...
...Evotec completed its previously announced acquisition of Renovis for about 35 million shares valued at E58.8... ...before the deal closed (see BioCentury, Sept. 24, 2007). Evotec AG (Xetra:EVT; NASDAQ:EVTC), Hamburg, Germany Renovis Inc....
...running into Phase III difficulties in late-stage testing include both a neuroprotectant, NXY-059 (Cerovive) from Renovis Inc.... ...NYSE:NVS; SWX:NOVN), Basel, Switzerland Paion AG (FSE:PA8), Aachen, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Renovis Inc....